The biopharmaceutical industry is undergoing a structural shift. For decades, contract development and manufacturing organisations (CDMOs) have operated through fragmented models, with drug substance ...

With utilities quoting four‑to‑ten‑year wait times — and one offering a 12‑year study period — Google says grid constraints ...

Micron's latest upsurge reflects that AI-driven upside extends beyond HBM, as accelerating DRAM and NAND pricing, reinforced ...